Want to Join Us?
Ready to take the next step in your career helping pioneer pharmaceutical innovation?
SAB Chair, Chief Scientific Officer
Dr. Aaron Cowley is the Chief Scientific Officer at Arranta Bio, having been a co-founder and the Chief Technical Officer of Captozyme, which served the microbiome CDMO market for 10 years since 2009 and merged with Arranta Bio in October 2019.
Dr. Cowley is a renowned member of the biotech community and was the recipient of the prestigious Ruth L. Kirschstein National Research Service Award for his post-doctoral work at the University of Georgia. His further work has resulted in 15 peer-reviewed journal articles.
Prior to establishing Captozyme in 2009, Dr. Cowley was a Scientist II/Preclinical Manager at OxThera, Inc. in Alachua, Florida.
He holds a bachelor’s degree in biochemistry from Benedictine College, a PhD in inorganic chemistry from the University of Kansas, and an MBA from the University of Florida.
Joy Cavagnaro, Ph.D.
Dr. Cavagnaro’s professional focus is preclinical development and regulatory strategies for drug, biologics and device combinations. She is a Diplomate of the American Board of Toxicology (DABT), Fellow of the Academy of Toxicological Sciences (ATS), Regulatory Affairs Certification (RAC) Fellow of the Regulatory Affairs Professional Society (RAPS), and president of Access BIO, a consultancy she founded that focuses on product development via science-based approaches.
Dr. Cavagnaro’s career spans academia, the contract research organization (CRO) and biotechnology industries, and government, and she currently serves as a Scientific Advisor for countless organizations.
Christin Jobin, Ph.D.
Dr. Christian Jobin is the Gatorade Trust Professor of Medicine at the University of Florida Gainesville. He is the co-leader of the Cancer Therapeutics Host Response research program at the University of Florida Health Cancer Center. Dr. Jobin’s research focuses on establishing the functional impact of bacteria in inflammation and carcinogenesis and deciphering mechanism of action. His research is supported by the National Institute of Health (NCI, NIAID and NIDDK) and by the Department of Defense. Dr. Jobin serves as a scientific advisor for Senda Biosciences and BiomX. He received his PhD in immunology/microbiology from Université Laval (Quebec, Canada).
Russ Middaugh, Ph.D.
Dr. Middaugh’s research efforts involve understanding the stability limits of biopharmaceuticals and vaccines. He is a distinguished professor at the University of Kansas School of Pharmacy and currently serves as a Scientific Advisor at Takeda Vaccines VitriVax.
Harris Wang, Ph.D.
Dr. Harris Wang is an Associate Professor at Columbia University jointly appointed in the Department of Systems Biology and the Department of Pathology and Cell Biology. Dr. Wang received his B.S. degrees in Mathematics and Physics from MIT and his Ph.D. in Biophysics from Harvard University. His research group develops enabling genomic technologies and synthetic biology tools to characterize and engineer microbial communities for a variety of applications. Dr. Wang is an Investigator of the Burroughs Wellcome Fund and the recipient of numerous awards including the NIH Director’s Early Independence Award, NSF CAREER, Sloan Research Fellowship, the Presidential Early Career Award for Scientists and Engineers (PECASE), and the Vilcek Prize for Creative Promise in Biomedical Science. Dr. Wang also serves as a Scientific Advisor for SNIPR Biome, FitBiomics, and Kingdom Supercultures.